These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 2856941

  • 1. Pertussis toxin treatment blocks the inhibition of somatostatin and increases the stimulation by forskolin of cyclic AMP accumulation and adrenocorticotropin secretion from mouse anterior pituitary tumor cells.
    Reisine T, Zhang YL, Sekura R.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):275-82. PubMed ID: 2856941
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Somatostatin desensitization: loss of the ability of somatostatin to inhibit cyclic AMP accumulation and adrenocorticotropin hormone release.
    Reisine T.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):14-20. PubMed ID: 6142943
    [Abstract] [Full Text] [Related]

  • 4. Somatostatin inhibition of cyclic AMP accumulation and adrenocorticotropin release from mouse anterior pituitary tumor cells: mode of action and self-regulation.
    Reisine TD.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1985 Apr; 19():169-77. PubMed ID: 2860779
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Stimulation of adrenocorticotropin secretion from AtT-20 cells by the calcium channel activator, BAY-K-8644, and its inhibition by somatostatin and carbachol.
    Heisler S.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):741-8. PubMed ID: 2416908
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Molecular mechanisms of corticotropin-releasing factor stimulation of calcium mobilization and adrenocorticotropin release from anterior pituitary tumor cells.
    Guild S, Reisine T.
    J Pharmacol Exp Ther; 1987 Apr; 241(1):125-30. PubMed ID: 3033199
    [Abstract] [Full Text] [Related]

  • 12. Muscarinic cholinergic receptors in mouse pituitary tumor cells: prolonged agonist pretreatment decreases receptor content and increases forskolin- and hormone-stimulated cyclic AMP synthesis and adrenocorticotropin secretion.
    Heisler S, Desjardins D, Nguyen MH.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):232-8. PubMed ID: 2981317
    [Abstract] [Full Text] [Related]

  • 13. Forskolin potentiation of cholera toxin-stimulated cyclic AMP accumulation in intact C6-2B cells. Evidence for enhanced Gs-C coupling.
    Barovsky K, Brooker G.
    Mol Pharmacol; 1985 Dec; 28(6):502-7. PubMed ID: 3001496
    [Abstract] [Full Text] [Related]

  • 14. Somatostatin inhibits corticotropin-releasing factor-stimulated adrenocorticotropin release, adenylate cyclase, and activation of adenosine 3',5'-monophosphate-dependent protein kinase isoenzymes in AtT20 cells.
    Litvin Y, Leiser M, Fleischer N, Erlichman J.
    Endocrinology; 1986 Aug; 119(2):737-45. PubMed ID: 2426087
    [Abstract] [Full Text] [Related]

  • 15. Pertussis toxin actions on the pituitary-derived 235-1 clone: effects of PGE1, cholera toxin, and forskolin on cyclic AMP metabolism and prolactin release.
    Cronin MJ, Myers GA, MacLeod RM, Hewlett EL.
    J Cyclic Nucleotide Protein Phosphor Res; 1983 Aug; 9(3):245-58. PubMed ID: 6199389
    [Abstract] [Full Text] [Related]

  • 16. Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase.
    Bozou JC, Amar S, Vincent JP, Kitabgi P.
    Mol Pharmacol; 1986 May; 29(5):489-96. PubMed ID: 3010077
    [Abstract] [Full Text] [Related]

  • 17. Influence of pertussis toxin on parathyroid hormone stimulated cyclic AMP production and phosphate transport in opossum kidney cells.
    Garcia JC, McConkey CL, Stokes TJ, Betts CR, Martin KJ.
    J Lab Clin Med; 1989 Dec; 114(6):691-6. PubMed ID: 2556491
    [Abstract] [Full Text] [Related]

  • 18. Somatostatin-14 and somatostatin-28 pretreatment down-regulate somatostatin-14 receptors and have biphasic effects on forskolin-stimulated cyclic adenosine, 3',5'-monophosphate synthesis and adrenocorticotropin secretion in mouse anterior pituitary tumor cells.
    Heisler S, Srikant CB.
    Endocrinology; 1985 Jul; 117(1):217-25. PubMed ID: 2861077
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin pretreatment desensitizes somatostatin receptors linked to adenylate cyclase and facilitates the stimulation of cyclic adenosine 3':5'-monophosphate accumulation in anterior pituitary tumor cells.
    Reisine TD, Takahashi JS.
    J Neurosci; 1984 Mar; 4(3):812-9. PubMed ID: 6142935
    [Abstract] [Full Text] [Related]

  • 20. Somatostatin inhibits multireceptor stimulation of cyclic AMP formation and corticotropin secretion in mouse pituitary tumor cells.
    Heisler S, Reisine TD, Hook VY, Axelrod J.
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6502-6. PubMed ID: 6128732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.